Spots Global Cancer Trial Database for IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)

Official Title: IMpact of BrcA Status on Survival in Adjuvant Breast Cancer (IMBASSA)

Study ID: NCT04012229

Conditions

Breast Cancer

BRCA1 Mutation

BRCA2 Mutation

Interventions

BRCA mutation

Study Description

Brief Summary: Relationship between the presence of the BRCA mutation (BReast Cancer) and outcomes is unclear in high-risk early breast cancers (BC). This study is a multi-center retrospective cohort of patients treated in region Franche-Comté for an early BC by neoadjuvant and/or adjuvant chemotherapy. The primary aim was to describe clinical and pathological characteristics considering BRCA mutated (BRCAm) patients versus BRCA wild type (BRCAwt) patients or untested patients. The second objective was to assess the prognostic impact of germinal BRCAm in this high-risk population.

Detailed Description: